Clinical Trial Update: Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated two fasting blood glucose targets to improve glucose control in adults with Type 2 diabetes treated with once-daily insulin detemir. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Detemir (Levemir) (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2009-12-22